Intrinsic value of Seres Therapeutics, Inc. (MCRB)
Live fair value data for Seres Therapeutics, Inc. (MCRB) is currently unavailable. Please check again shortly.
Current Price: $122.00
Valuation: Undervalued
Confidence: 8.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Seres Therapeutics, Inc. (MCRB) undervalued or overvalued?
Based on the current model output, Seres Therapeutics, Inc. appears to be undervalued with a upside of 35.00%.
Fair value vs market price — Seres Therapeutics, Inc. (MCRB)
Unlock premium access to view the live fair value comparison against current market price for MCRB.
Frequently Asked Questions - MCRB
How is MCRB intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for MCRB.
Is MCRB undervalued or overvalued right now?
MCRB is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for MCRB: open their intrinsic value pages.